New Investor PrairieGold Venture Partners Joins Existing Institutional Investor Line-up of Sanderling Ventures, vSpring Capital and Mesa Verde Venture Partners SALT LAKE CITY--(BUSINESS WIRE)-- ...

SALT LAKE CITY, Dec. 19 -- LineaGen Inc. (http://www.LineaGen.com), a biomarker discovery company created to discover and commercialize significant molecular ...

SAN DIEGO, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the release of EpiPanel Dx PLUS™ by its diagnostics services business, Lineagen. The new laboratory ...

- Lineagen's next-generation FirstStepDx® genetic test to incorporate novel variants; launch planned for as early as fourth quarter of 2012 - Dr. Hakonarson, Director of CHOP's Center for Applied ...

Lineagen, Inc., an innovative molecular diagnostics company focused on complex, genetically linked disorders, and Fast Forward, LLC, a nonprofit subsidiary of the National Multiple Sclerosis Society, ...

SALT LAKE CITY, Jan. 10, 2019 /PRNewswire/ -- Lineagen, a leading provider of clinical genetic testing, is partnering with PWNHealth to expand access to its clinical genetic tests. PWNHealth's ...

Fast Forward will provide $622,000 for diagnostic and prognostic tools. Lineagen, a molecular diagnostics company, and Fast Forward, a nonprofit subsidiary of the National Multiple Sclerosis Society, ...

SALT LAKE CITY, Dec. 14, 2011 /PRNewswire/ -- Lineagen, Inc., an innovative molecular diagnostics company focused on complex, genetically linked disorders, and Fast Forward, LLC, a nonprofit ...

SALT LAKE CITY--(BUSINESS WIRE)--Lineagen, Inc., an innovative genetics diagnostics company focused on complex neurodevelopmental disorders, announced today the publication of a major study revealing ...

SALT LAKE CITY--(BUSINESS WIRE)--Lineagen, Inc. (www.lineagen.com), a developer of innovative genomic tests and services for the screening, evaluation and diagnosis of complex disorders and diseases ...